| 前收盘价格 | 91.88 |
| 收盘价格 | 92.33 |
| 成交量 | 2,055,038 |
| 平均成交量 (3个月) | 1,421,455 |
| 市值 | 12,995,208,192 |
| 市盈率 (P/E TTM) | 31.14 |
| 预期市盈率 (P/E Forward) | 21.05 |
| 价格/销量 (P/S) | 4.67 |
| 股市价格/股市净资产 (P/B) | 2.85 |
| 52周波幅 | |
| 利润日期 | 7 May 2026 |
| 营业毛利率 | 7.39% |
| 营业利益率 (TTM) | 16.43% |
| 稀释每股收益 (EPS TTM) | 1.34 |
| 季度收入增长率 (YOY) | -1.40% |
| 季度盈利增长率 (YOY) | 76.30% |
| 总债务/股东权益 (D/E MRQ) | 2.27% |
| 流动比率 (MRQ) | 4.45 |
| 营业现金流 (OCF TTM) | 645.55 M |
| 杠杆自由现金流 (LFCF TTM) | 636.51 M |
| 资产报酬率 (ROA TTM) | 5.84% |
| 股东权益报酬率 (ROE TTM) | 4.63% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | Globus Medical, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
0.2
| 分析师共识 | 1.5 |
| 内部交易活动 | -1.5 |
| 价格波动 | -0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.20 |
|
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.69% |
| 机构持股比例 | 100.63% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 123.00 (Barclays, 27.83%) | 购买 |
| 中 | 112.00 (16.40%) | |
| 低 | 87.00 (Freedom Capital Markets, -9.58%) | 保留 |
| 平均值 | 107.86 (12.10%) | |
| 总计 | 6 购买, 1 保留 | |
| 平均价格@调整类型 | 92.62 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wells Fargo | 26 Feb 2026 | 104.00 (8.09%) | 购买 | 96.71 |
| Barclays | 25 Feb 2026 | 123.00 (27.83%) | 购买 | 96.22 |
| Needham | 25 Feb 2026 | 114.00 (18.48%) | 购买 | 96.22 |
| 30 Jan 2026 | 112.00 (16.40%) | 购买 | 90.68 | |
| Canaccord Genuity | 09 Jan 2026 | 112.00 (16.40%) | 购买 | 94.47 |
| 17 Dec 2025 | 105.00 (9.12%) | 购买 | 85.06 | |
| Piper Sandler | 08 Jan 2026 | 115.00 (19.52%) | 购买 | 94.62 |
| Freedom Capital Markets | 17 Dec 2025 | 87.00 (-9.58%) | 保留 | 85.06 |
| RBC Capital | 17 Dec 2025 | 100.00 (3.93%) | 购买 | 85.06 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| HULLER KELLY | - | 96.22 | -20,000 | -1,924,400 |
| 累积净数量 | -20,000 | |||
| 累积净值 ($) | -1,924,400 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 96.22 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| HULLER KELLY | 职员 | 25 Feb 2026 | 自动卖出 (-) | 20,000 | 96.22 | 1,924,400 |
| HULLER KELLY | 职员 | 25 Feb 2026 | 执行期权 | 20,000 | - | - |
| 日期 | 类型 | 细节 |
|---|---|---|
| 07 Jan 2026 | 公告 | Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合